

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | growth hormone receptor signaling pathway (GO:0060396) | 5.34682035 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.23432159 |
| 3 | cellular response to growth hormone stimulus (GO:0071378) | 4.73455046 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.70257132 |
| 5 | positive thymic T cell selection (GO:0045059) | 4.65304759 |
| 6 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.61587456 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.29150595 |
| 8 | B cell mediated immunity (GO:0019724) | 4.15748598 |
| 9 | positive T cell selection (GO:0043368) | 4.09288169 |
| 10 | cellular response to ethanol (GO:0071361) | 3.89459197 |
| 11 | leukocyte degranulation (GO:0043299) | 3.81426470 |
| 12 | negative regulation of interleukin-12 production (GO:0032695) | 3.80435799 |
| 13 | response to interferon-beta (GO:0035456) | 3.77943612 |
| 14 | natural killer cell activation involved in immune response (GO:0002323) | 3.72414718 |
| 15 | negative regulation of cell killing (GO:0031342) | 3.58303425 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.58303425 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.56905053 |
| 18 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.55986126 |
| 19 | platelet dense granule organization (GO:0060155) | 3.50002227 |
| 20 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.46038201 |
| 21 | mast cell activation involved in immune response (GO:0002279) | 3.32731389 |
| 22 | mast cell degranulation (GO:0043303) | 3.32731389 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 3.31413312 |
| 24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.29717053 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 3.25202137 |
| 26 | phagocytosis, engulfment (GO:0006911) | 3.24085410 |
| 27 | thymic T cell selection (GO:0045061) | 3.23700632 |
| 28 | mast cell activation (GO:0045576) | 3.23528640 |
| 29 | T cell selection (GO:0045058) | 3.23200138 |
| 30 | ribosomal small subunit assembly (GO:0000028) | 3.22059891 |
| 31 | definitive hemopoiesis (GO:0060216) | 3.20963947 |
| 32 | regulation of tolerance induction (GO:0002643) | 3.17402010 |
| 33 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.14029705 |
| 34 | neutrophil activation involved in immune response (GO:0002283) | 3.11686766 |
| 35 | pinocytosis (GO:0006907) | 3.11682632 |
| 36 | regulation of T cell tolerance induction (GO:0002664) | 3.10624726 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 3.10017313 |
| 38 | response to type I interferon (GO:0034340) | 3.07929903 |
| 39 | cellular response to interferon-beta (GO:0035458) | 3.07576072 |
| 40 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.06508108 |
| 41 | type I interferon signaling pathway (GO:0060337) | 3.06345463 |
| 42 | cellular response to type I interferon (GO:0071357) | 3.06345463 |
| 43 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04336276 |
| 44 | positive regulation of antigen processing and presentation (GO:0002579) | 3.04162877 |
| 45 | positive regulation of tolerance induction (GO:0002645) | 3.04047306 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 3.02979150 |
| 47 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.02386025 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 2.97573970 |
| 49 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.97381733 |
| 50 | defense response to protozoan (GO:0042832) | 2.95820559 |
| 51 | T cell receptor signaling pathway (GO:0050852) | 2.95288382 |
| 52 | response to protozoan (GO:0001562) | 2.92368990 |
| 53 | T cell migration (GO:0072678) | 2.92343921 |
| 54 | cellular response to interleukin-15 (GO:0071350) | 2.91177209 |
| 55 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.90649004 |
| 56 | detection of external biotic stimulus (GO:0098581) | 2.89632191 |
| 57 | T cell costimulation (GO:0031295) | 2.88948450 |
| 58 | detection of other organism (GO:0098543) | 2.88590876 |
| 59 | regulation of hypersensitivity (GO:0002883) | 2.87103160 |
| 60 | positive regulation of mast cell activation (GO:0033005) | 2.86906885 |
| 61 | lymphocyte costimulation (GO:0031294) | 2.84390549 |
| 62 | interferon-gamma production (GO:0032609) | 2.83183762 |
| 63 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.83165896 |
| 64 | response to peptidoglycan (GO:0032494) | 2.82349116 |
| 65 | response to interferon-alpha (GO:0035455) | 2.82305668 |
| 66 | regulation of oxidative stress-induced neuron death (GO:1903203) | 2.82064146 |
| 67 | daunorubicin metabolic process (GO:0044597) | 2.81096822 |
| 68 | polyketide metabolic process (GO:0030638) | 2.81096822 |
| 69 | doxorubicin metabolic process (GO:0044598) | 2.81096822 |
| 70 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.80539314 |
| 71 | T-helper 1 type immune response (GO:0042088) | 2.78842803 |
| 72 | regulation of antigen processing and presentation (GO:0002577) | 2.78838480 |
| 73 | regulation of germinal center formation (GO:0002634) | 2.78823586 |
| 74 | cellular response to interferon-gamma (GO:0071346) | 2.77882835 |
| 75 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.73457117 |
| 76 | immunoglobulin mediated immune response (GO:0016064) | 2.73079418 |
| 77 | dendritic cell chemotaxis (GO:0002407) | 2.72495179 |
| 78 | negative T cell selection (GO:0043383) | 2.72170347 |
| 79 | negative regulation of granulocyte differentiation (GO:0030853) | 2.71872884 |
| 80 | neutrophil activation (GO:0042119) | 2.71767039 |
| 81 | response to muramyl dipeptide (GO:0032495) | 2.71706607 |
| 82 | endothelium development (GO:0003158) | 2.71641540 |
| 83 | negative regulation of phagocytosis (GO:0050765) | 2.69849717 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 2.69609607 |
| 85 | regulation of B cell differentiation (GO:0045577) | 2.69143896 |
| 86 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.68372442 |
| 87 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.66917558 |
| 88 | positive regulation of T cell migration (GO:2000406) | 2.66526524 |
| 89 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.66337531 |
| 90 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.65232903 |
| 91 | detection of molecule of bacterial origin (GO:0032490) | 2.64438604 |
| 92 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.63910031 |
| 93 | positive regulation of mast cell degranulation (GO:0043306) | 2.63910031 |
| 94 | germinal center formation (GO:0002467) | 2.63467135 |
| 95 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.63293271 |
| 96 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.63158169 |
| 97 | positive regulation of chemokine secretion (GO:0090197) | 2.63080774 |
| 98 | cellular extravasation (GO:0045123) | 2.62969680 |
| 99 | regulation of T cell migration (GO:2000404) | 2.62369859 |
| 100 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.62185377 |
| 101 | RNA destabilization (GO:0050779) | 2.61502872 |
| 102 | detection of biotic stimulus (GO:0009595) | 2.61049630 |
| 103 | negative regulation of T cell mediated immunity (GO:0002710) | 2.60836365 |
| 104 | response to interferon-gamma (GO:0034341) | 2.60400583 |
| 105 | microglial cell activation (GO:0001774) | 2.59167096 |
| 106 | dendritic cell migration (GO:0036336) | 2.59048096 |
| 107 | leukocyte aggregation (GO:0070486) | 2.58108354 |
| 108 | positive regulation of interferon-beta production (GO:0032728) | 2.57474672 |
| 109 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57372877 |
| 110 | positive regulation of macrophage cytokine production (GO:0060907) | 2.57339144 |
| 111 | regulation of regulatory T cell differentiation (GO:0045589) | 2.57094080 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 2.55292838 |
| 113 | positive regulation of macrophage differentiation (GO:0045651) | 2.54866898 |
| 114 | cellular response to exogenous dsRNA (GO:0071360) | 2.54327912 |
| 115 | respiratory burst (GO:0045730) | 2.53914960 |
| 116 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53598447 |
| 117 | adaptive immune response (GO:0002250) | 2.53580017 |
| 118 | adenosine metabolic process (GO:0046085) | 2.53414284 |
| 119 | regulation of B cell apoptotic process (GO:0002902) | 2.53323584 |
| 120 | response to interleukin-15 (GO:0070672) | 2.53249872 |
| 121 | negative thymic T cell selection (GO:0045060) | 2.52207533 |
| 122 | response to hydroperoxide (GO:0033194) | 2.52064208 |
| 123 | regulation of macrophage chemotaxis (GO:0010758) | 2.50362020 |
| 124 | megakaryocyte development (GO:0035855) | 2.49433057 |
| 125 | cell differentiation involved in metanephros development (GO:0072202) | 2.48729180 |
| 126 | myeloid dendritic cell activation (GO:0001773) | 2.48365142 |
| 127 | lymph vessel development (GO:0001945) | 2.47849860 |
| 128 | regulation of lymphocyte migration (GO:2000401) | 2.47502131 |
| 129 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.47156135 |
| 130 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.47156135 |
| 131 | positive regulation of lymphocyte migration (GO:2000403) | 2.46927803 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.46133243 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.46133243 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.46133243 |
| 135 | positive regulation by symbiont of host defense response (GO:0052509) | 2.46133243 |
| 136 | modulation by symbiont of host defense response (GO:0052031) | 2.46133243 |
| 137 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.46133243 |
| 138 | detection of bacterium (GO:0016045) | 2.45528644 |
| 139 | mature B cell differentiation involved in immune response (GO:0002313) | 2.44962306 |
| 140 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.44898348 |
| 141 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.44681853 |
| 142 | macrophage activation (GO:0042116) | 2.44458207 |
| 143 | hepatocyte apoptotic process (GO:0097284) | 2.43893175 |
| 144 | myeloid leukocyte activation (GO:0002274) | 2.42965975 |
| 145 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.41819595 |
| 146 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.41747309 |
| 147 | regulation of mast cell activation (GO:0033003) | 2.41516541 |
| 148 | regulation of interleukin-8 secretion (GO:2000482) | 2.41425602 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.40626274 |
| 150 | granulocyte activation (GO:0036230) | 2.40589610 |
| 151 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.39611816 |
| 152 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.37855641 |
| 153 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.37347991 |
| 154 | regulation of T cell chemotaxis (GO:0010819) | 2.36488556 |
| 155 | positive regulation of T cell chemotaxis (GO:0010820) | 2.36488556 |
| 156 | negative regulation of viral genome replication (GO:0045071) | 2.35411638 |
| 157 | angiogenesis involved in wound healing (GO:0060055) | 2.34179671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.29250438 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.57622906 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.13769869 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.19872668 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.09384388 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.48787251 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.33942542 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.15769676 |
| 9 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.94730400 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90967132 |
| 11 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83232096 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.82905791 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82316380 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.82109519 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.67422146 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.66620114 |
| 17 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.40459273 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34201625 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32874752 |
| 20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.27046389 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.26951265 |
| 22 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.25453683 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.24254902 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17051366 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15585273 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.14154347 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08743023 |
| 28 | MYB_26560356_Chip-Seq_TH2_Human | 2.01032914 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00346067 |
| 30 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.99418642 |
| 31 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.93349308 |
| 32 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.92793351 |
| 33 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.79713889 |
| 34 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.73963958 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73431115 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.67990037 |
| 37 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55448409 |
| 38 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51663924 |
| 39 | * MYB_26560356_Chip-Seq_TH1_Human | 1.50187715 |
| 40 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48693200 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48355752 |
| 42 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.46508347 |
| 43 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.45691719 |
| 44 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.42956139 |
| 45 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41355671 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.40343083 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.38109932 |
| 48 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37633502 |
| 49 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.36696547 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35064076 |
| 51 | MAF_26560356_Chip-Seq_TH1_Human | 1.34888000 |
| 52 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34259674 |
| 53 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31354216 |
| 54 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31239349 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30755195 |
| 56 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.29851632 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29373981 |
| 58 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29228799 |
| 59 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.27186730 |
| 60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26837459 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.26386355 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.26351198 |
| 63 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25365782 |
| 64 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.25213428 |
| 65 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21213659 |
| 66 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.16698858 |
| 67 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16669457 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.16089706 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15295329 |
| 70 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15129813 |
| 71 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13663237 |
| 72 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11993491 |
| 73 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.11335434 |
| 74 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.10041958 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09311512 |
| 76 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.08259000 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.06993301 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05248721 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04648243 |
| 80 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03185202 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03014548 |
| 82 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.00991311 |
| 83 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.99200885 |
| 84 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.98969169 |
| 85 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.98752543 |
| 86 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.98134856 |
| 87 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97809536 |
| 88 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.96997185 |
| 89 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96812654 |
| 90 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.95060615 |
| 91 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.94687263 |
| 92 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94409471 |
| 93 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94042191 |
| 94 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93907775 |
| 95 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92474167 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92467648 |
| 97 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92186110 |
| 98 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.92089487 |
| 99 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91323554 |
| 100 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.91191035 |
| 101 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90881279 |
| 102 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90500985 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.90209773 |
| 104 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89451553 |
| 105 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.89230479 |
| 106 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87377107 |
| 107 | SPI1_23127762_ChIP-Seq_K562_Human | 0.87098640 |
| 108 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85680100 |
| 109 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.84613307 |
| 110 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84567843 |
| 111 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.83772463 |
| 112 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.82922746 |
| 113 | AR_20517297_ChIP-Seq_VCAP_Human | 0.82777072 |
| 114 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.81183659 |
| 115 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.81033904 |
| 116 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.80735833 |
| 117 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80539195 |
| 118 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80400627 |
| 119 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79933924 |
| 120 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.79909948 |
| 121 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79909948 |
| 122 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.78392114 |
| 123 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.78173849 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78007541 |
| 125 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77618281 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77618281 |
| 127 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.77055296 |
| 128 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77049321 |
| 129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.75950196 |
| 130 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.74071828 |
| 131 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73900202 |
| 132 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73900202 |
| 133 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.72444537 |
| 134 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.71484347 |
| 135 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.70859069 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.70720670 |
| 137 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.70067305 |
| 138 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.69018922 |
| 139 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.68294732 |
| 140 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.67442124 |
| 141 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.62808662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.64894553 |
| 2 | MP0000569_abnormal_digit_pigmentation | 3.45503243 |
| 3 | MP0003724_increased_susceptibility_to | 3.43952086 |
| 4 | MP0005671_abnormal_response_to | 3.29352321 |
| 5 | MP0009785_altered_susceptibility_to | 2.98435544 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.66809178 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.45117062 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.35372864 |
| 9 | MP0005025_abnormal_response_to | 2.34270731 |
| 10 | MP0010368_abnormal_lymphatic_system | 2.32496954 |
| 11 | MP0002419_abnormal_innate_immunity | 2.30738479 |
| 12 | MP0006082_CNS_inflammation | 2.30058397 |
| 13 | MP0001800_abnormal_humoral_immune | 2.26824416 |
| 14 | MP0001879_abnormal_lymphatic_vessel | 2.21918001 |
| 15 | MP0005000_abnormal_immune_tolerance | 2.21531426 |
| 16 | MP0003303_peritoneal_inflammation | 2.17958050 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.15927040 |
| 18 | MP0000685_abnormal_immune_system | 2.13595324 |
| 19 | MP0002723_abnormal_immune_serum | 2.12458436 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.10638818 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.08243375 |
| 22 | MP0001819_abnormal_immune_cell | 2.03674931 |
| 23 | MP0003436_decreased_susceptibility_to | 2.03669547 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.03402834 |
| 25 | MP0001790_abnormal_immune_system | 2.02580311 |
| 26 | MP0005387_immune_system_phenotype | 2.02580311 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.90026851 |
| 28 | MP0001853_heart_inflammation | 1.84895927 |
| 29 | MP0004147_increased_porphyrin_level | 1.80492278 |
| 30 | MP0009697_abnormal_copulation | 1.80396069 |
| 31 | MP0002006_tumorigenesis | 1.78636917 |
| 32 | MP0002405_respiratory_system_inflammati | 1.78212130 |
| 33 | MP0006054_spinal_hemorrhage | 1.76775278 |
| 34 | MP0000465_gastrointestinal_hemorrhage | 1.76284570 |
| 35 | MP0009379_abnormal_foot_pigmentation | 1.74594640 |
| 36 | MP0005409_darkened_coat_color | 1.70030936 |
| 37 | MP0002398_abnormal_bone_marrow | 1.66482022 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.62680435 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.62286494 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.61658552 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.56909118 |
| 42 | MP0000716_abnormal_immune_system | 1.56278956 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.54780613 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.50596000 |
| 45 | MP0003828_pulmonary_edema | 1.45165620 |
| 46 | MP0003172_abnormal_lysosome_physiology | 1.43822907 |
| 47 | MP0009333_abnormal_splenocyte_physiolog | 1.42262747 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.42024325 |
| 49 | MP0001873_stomach_inflammation | 1.40874776 |
| 50 | MP0003943_abnormal_hepatobiliary_system | 1.40147789 |
| 51 | MP0002009_preneoplasia | 1.40039733 |
| 52 | MP0002722_abnormal_immune_system | 1.38410818 |
| 53 | MP0002132_abnormal_respiratory_system | 1.37675963 |
| 54 | MP0009764_decreased_sensitivity_to | 1.36497424 |
| 55 | MP0001845_abnormal_inflammatory_respons | 1.36362312 |
| 56 | MP0003866_abnormal_defecation | 1.34783448 |
| 57 | MP0002429_abnormal_blood_cell | 1.32720379 |
| 58 | MP0005397_hematopoietic_system_phenotyp | 1.31613821 |
| 59 | MP0001545_abnormal_hematopoietic_system | 1.31613821 |
| 60 | MP0000343_altered_response_to | 1.28837035 |
| 61 | MP0003075_altered_response_to | 1.28760125 |
| 62 | MP0008469_abnormal_protein_level | 1.26466448 |
| 63 | MP0006292_abnormal_olfactory_placode | 1.24046154 |
| 64 | MP0004381_abnormal_hair_follicle | 1.22994193 |
| 65 | MP0001851_eye_inflammation | 1.22686930 |
| 66 | MP0002933_joint_inflammation | 1.22470852 |
| 67 | MP0000015_abnormal_ear_pigmentation | 1.21225421 |
| 68 | MP0003279_aneurysm | 1.20116996 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.19643921 |
| 70 | MP0005174_abnormal_tail_pigmentation | 1.18042438 |
| 71 | MP0003195_calcinosis | 1.17993171 |
| 72 | MP0003690_abnormal_glial_cell | 1.17185396 |
| 73 | MP0000604_amyloidosis | 1.16968085 |
| 74 | MP0001533_abnormal_skeleton_physiology | 1.16732130 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.15941576 |
| 76 | MP0000858_altered_metastatic_potential | 1.14390035 |
| 77 | MP0009278_abnormal_bone_marrow | 1.13830407 |
| 78 | MP0002638_abnormal_pupillary_reflex | 1.12404399 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.09999414 |
| 80 | MP0000767_abnormal_smooth_muscle | 1.06756048 |
| 81 | MP0005171_absent_coat_pigmentation | 1.03498468 |
| 82 | MP0003186_abnormal_redox_activity | 1.02836198 |
| 83 | MP0002095_abnormal_skin_pigmentation | 1.02246741 |
| 84 | MP0009763_increased_sensitivity_to | 0.99533924 |
| 85 | MP0004947_skin_inflammation | 0.99147446 |
| 86 | MP0008058_abnormal_DNA_repair | 0.97854731 |
| 87 | MP0000249_abnormal_blood_vessel | 0.97783680 |
| 88 | MP0000372_irregular_coat_pigmentation | 0.97731206 |
| 89 | MP0003252_abnormal_bile_duct | 0.95033434 |
| 90 | MP0000490_abnormal_crypts_of | 0.94384723 |
| 91 | MP0005365_abnormal_bile_salt | 0.94109999 |
| 92 | MP0002254_reproductive_system_inflammat | 0.89215178 |
| 93 | MP0003300_gastrointestinal_ulcer | 0.88817923 |
| 94 | MP0003448_altered_tumor_morphology | 0.87593321 |
| 95 | MP0004782_abnormal_surfactant_physiolog | 0.84018130 |
| 96 | MP0004084_abnormal_cardiac_muscle | 0.83028933 |
| 97 | MP0010329_abnormal_lipoprotein_level | 0.82551614 |
| 98 | MP0005670_abnormal_white_adipose | 0.81288518 |
| 99 | MP0004130_abnormal_muscle_cell | 0.80138710 |
| 100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78569695 |
| 101 | MP0002998_abnormal_bone_remodeling | 0.76648195 |
| 102 | MP0002098_abnormal_vibrissa_morphology | 0.75600858 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.74683795 |
| 104 | MP0001188_hyperpigmentation | 0.73850090 |
| 105 | MP0004883_abnormal_blood_vessel | 0.70789736 |
| 106 | MP0008057_abnormal_DNA_replication | 0.70369095 |
| 107 | MP0005390_skeleton_phenotype | 0.70037231 |
| 108 | MP0002138_abnormal_hepatobiliary_system | 0.69857652 |
| 109 | MP0005085_abnormal_gallbladder_physiolo | 0.69793036 |
| 110 | MP0000613_abnormal_salivary_gland | 0.69768726 |
| 111 | MP0008775_abnormal_heart_ventricle | 0.69252126 |
| 112 | MP0005164_abnormal_response_to | 0.69075796 |
| 113 | MP0003806_abnormal_nucleotide_metabolis | 0.68835075 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.68141533 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.67679923 |
| 116 | MP0003941_abnormal_skin_development | 0.67647739 |
| 117 | MP0005166_decreased_susceptibility_to | 0.67646037 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.67475707 |
| 119 | MP0001764_abnormal_homeostasis | 0.65825455 |
| 120 | MP0005408_hypopigmentation | 0.65344783 |
| 121 | MP0001191_abnormal_skin_condition | 0.64851097 |
| 122 | MP0006072_abnormal_retinal_apoptosis | 0.64377530 |
| 123 | MP0003795_abnormal_bone_structure | 0.63375818 |
| 124 | MP0000516_abnormal_urinary_system | 0.62708168 |
| 125 | MP0005367_renal/urinary_system_phenotyp | 0.62708168 |
| 126 | MP0005595_abnormal_vascular_smooth | 0.62353808 |
| 127 | MP0005310_abnormal_salivary_gland | 0.61958970 |
| 128 | MP0002928_abnormal_bile_duct | 0.61929350 |
| 129 | MP0000371_diluted_coat_color | 0.61665962 |
| 130 | MP0001915_intracranial_hemorrhage | 0.61386483 |
| 131 | MP0000920_abnormal_myelination | 0.61111094 |
| 132 | MP0001663_abnormal_digestive_system | 0.60655307 |
| 133 | MP0005360_urolithiasis | 0.60617561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.31360888 |
| 2 | Spontaneous hematomas (HP:0007420) | 4.12232502 |
| 3 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.97280050 |
| 4 | Myositis (HP:0100614) | 3.96416627 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.79325421 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.77232612 |
| 7 | Chronic diarrhea (HP:0002028) | 3.32123493 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.24148198 |
| 9 | Orchitis (HP:0100796) | 3.22493613 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 3.21455088 |
| 11 | Optic neuritis (HP:0100653) | 3.21455088 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 3.19025348 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 3.12290863 |
| 14 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.12290863 |
| 15 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.12290863 |
| 16 | Prolonged bleeding time (HP:0003010) | 3.11548362 |
| 17 | Thrombocytosis (HP:0001894) | 3.09105616 |
| 18 | Recurrent skin infections (HP:0001581) | 3.08580288 |
| 19 | Abnormality of the prostate (HP:0008775) | 3.07601981 |
| 20 | Thyroiditis (HP:0100646) | 3.05241547 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 3.00854702 |
| 22 | T lymphocytopenia (HP:0005403) | 2.99441701 |
| 23 | Reduced antithrombin III activity (HP:0001976) | 2.98588414 |
| 24 | Abnormality of T cell number (HP:0011839) | 2.95951252 |
| 25 | Recurrent fungal infections (HP:0002841) | 2.93956041 |
| 26 | Glomerulonephritis (HP:0000099) | 2.84907815 |
| 27 | Hypoplasia of the thymus (HP:0000778) | 2.84879505 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 2.82205905 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.80089423 |
| 30 | Recurrent cutaneous fungal infections (HP:0011370) | 2.80089423 |
| 31 | Recurrent viral infections (HP:0004429) | 2.78257699 |
| 32 | Vacuolated lymphocytes (HP:0001922) | 2.77469546 |
| 33 | Epistaxis (HP:0000421) | 2.72568340 |
| 34 | Combined immunodeficiency (HP:0005387) | 2.72501884 |
| 35 | IgM deficiency (HP:0002850) | 2.72260645 |
| 36 | Prostate neoplasm (HP:0100787) | 2.69411319 |
| 37 | Increased cerebral lipofuscin (HP:0011813) | 2.62286769 |
| 38 | Abnormality of the pleura (HP:0002103) | 2.60263828 |
| 39 | Congenital stationary night blindness (HP:0007642) | 2.58179729 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 2.57176308 |
| 41 | Meningitis (HP:0001287) | 2.56625014 |
| 42 | Petechiae (HP:0000967) | 2.56457420 |
| 43 | Reticulocytopenia (HP:0001896) | 2.56422429 |
| 44 | Abnormality of eosinophils (HP:0001879) | 2.55133880 |
| 45 | Hemoptysis (HP:0002105) | 2.49586721 |
| 46 | Abnormality of T cells (HP:0002843) | 2.48791266 |
| 47 | Mutism (HP:0002300) | 2.48715976 |
| 48 | Leukocytosis (HP:0001974) | 2.47664972 |
| 49 | IgG deficiency (HP:0004315) | 2.46607747 |
| 50 | Eosinophilia (HP:0001880) | 2.45789746 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.41102661 |
| 52 | B lymphocytopenia (HP:0010976) | 2.41102661 |
| 53 | Pulmonary fibrosis (HP:0002206) | 2.40304091 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.39877525 |
| 55 | Mediastinal lymphadenopathy (HP:0100721) | 2.37733368 |
| 56 | Pustule (HP:0200039) | 2.35498275 |
| 57 | Renal cortical cysts (HP:0000803) | 2.34627290 |
| 58 | 3-Methylglutaconic aciduria (HP:0003535) | 2.34248173 |
| 59 | Joint hemorrhage (HP:0005261) | 2.34199325 |
| 60 | Agammaglobulinemia (HP:0004432) | 2.34127248 |
| 61 | Chronic obstructive pulmonary disease (HP:0006510) | 2.33292953 |
| 62 | Obstructive lung disease (HP:0006536) | 2.33292953 |
| 63 | Chest pain (HP:0100749) | 2.32632894 |
| 64 | Abnormality of macrophages (HP:0004311) | 2.31839572 |
| 65 | Hematochezia (HP:0002573) | 2.29886973 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28600041 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.27769636 |
| 68 | Keratoconjunctivitis sicca (HP:0001097) | 2.26476092 |
| 69 | Stomatitis (HP:0010280) | 2.26122415 |
| 70 | Encephalitis (HP:0002383) | 2.25486985 |
| 71 | Vasculitis (HP:0002633) | 2.25404204 |
| 72 | Type 2 muscle fiber atrophy (HP:0003554) | 2.24964719 |
| 73 | Granulocytopenia (HP:0001913) | 2.23941135 |
| 74 | Abnormality of the renal collecting system (HP:0004742) | 2.21540028 |
| 75 | Colitis (HP:0002583) | 2.20755145 |
| 76 | Type I transferrin isoform profile (HP:0003642) | 2.20038244 |
| 77 | Pulmonary infiltrates (HP:0002113) | 2.19553622 |
| 78 | Chromsome breakage (HP:0040012) | 2.18442657 |
| 79 | Microcytic anemia (HP:0001935) | 2.16062930 |
| 80 | Purpura (HP:0000979) | 2.14840075 |
| 81 | Gangrene (HP:0100758) | 2.14341672 |
| 82 | Hypoproteinemia (HP:0003075) | 2.13783515 |
| 83 | Gingival bleeding (HP:0000225) | 2.13711870 |
| 84 | Mesangial abnormality (HP:0001966) | 2.12055855 |
| 85 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.11668960 |
| 86 | Chronic otitis media (HP:0000389) | 2.11506353 |
| 87 | Ulnar claw (HP:0001178) | 2.09089490 |
| 88 | Patchy hypopigmentation of hair (HP:0011365) | 2.08349646 |
| 89 | Autoimmune thrombocytopenia (HP:0001973) | 2.07928402 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.07867108 |
| 91 | Autoimmune hemolytic anemia (HP:0001890) | 2.05892485 |
| 92 | Dysostosis multiplex (HP:0000943) | 2.05669402 |
| 93 | Complement deficiency (HP:0004431) | 2.04625547 |
| 94 | Agnosia (HP:0010524) | 2.03784690 |
| 95 | Periodontitis (HP:0000704) | 2.03135868 |
| 96 | Keratoconjunctivitis (HP:0001096) | 2.03037650 |
| 97 | Abnormality of DNA repair (HP:0003254) | 2.02840377 |
| 98 | Increased IgM level (HP:0003496) | 2.02649026 |
| 99 | Pulmonary embolism (HP:0002204) | 2.01507788 |
| 100 | Abnormality of the peritoneum (HP:0002585) | 2.01281878 |
| 101 | Polyneuropathy (HP:0001271) | 2.00948875 |
| 102 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98168451 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 1.97760779 |
| 104 | Increased IgE level (HP:0003212) | 1.96766125 |
| 105 | Acute myeloid leukemia (HP:0004808) | 1.95387105 |
| 106 | Nephritis (HP:0000123) | 1.95177884 |
| 107 | Impaired platelet aggregation (HP:0003540) | 1.95059131 |
| 108 | Abnormal platelet function (HP:0011869) | 1.95059131 |
| 109 | Loss of speech (HP:0002371) | 1.93405743 |
| 110 | Abnormal drinking behavior (HP:0030082) | 1.93373103 |
| 111 | Polydipsia (HP:0001959) | 1.93373103 |
| 112 | Abnormality of male internal genitalia (HP:0000022) | 1.92228611 |
| 113 | Lymphoma (HP:0002665) | 1.91507225 |
| 114 | Recurrent pneumonia (HP:0006532) | 1.91165449 |
| 115 | Portal hypertension (HP:0001409) | 1.91024780 |
| 116 | Urticaria (HP:0001025) | 1.90092522 |
| 117 | Scanning speech (HP:0002168) | 1.89716636 |
| 118 | Basal ganglia calcification (HP:0002135) | 1.89499481 |
| 119 | Disinhibition (HP:0000734) | 1.89403188 |
| 120 | White forelock (HP:0002211) | 1.89386815 |
| 121 | Muscle fiber atrophy (HP:0100295) | 1.89309800 |
| 122 | Nonimmune hydrops fetalis (HP:0001790) | 1.88193597 |
| 123 | Arterial thrombosis (HP:0004420) | 1.88011501 |
| 124 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87519726 |
| 125 | Hypergammaglobulinemia (HP:0010702) | 1.86625861 |
| 126 | Ectropion (HP:0000656) | 1.86111604 |
| 127 | Hypothermia (HP:0002045) | 1.86035131 |
| 128 | Prolonged partial thromboplastin time (HP:0003645) | 1.85368515 |
| 129 | Menorrhagia (HP:0000132) | 1.84526046 |
| 130 | Stomach cancer (HP:0012126) | 1.83909927 |
| 131 | Lymphopenia (HP:0001888) | 1.83838633 |
| 132 | Papilloma (HP:0012740) | 1.82705116 |
| 133 | Verrucae (HP:0200043) | 1.82705116 |
| 134 | Thrombophlebitis (HP:0004418) | 1.82052585 |
| 135 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.81785156 |
| 136 | Villous atrophy (HP:0011473) | 1.81785156 |
| 137 | Abnormal biliary tract physiology (HP:0012439) | 1.80407135 |
| 138 | Bile duct proliferation (HP:0001408) | 1.80407135 |
| 139 | Abnormal spermatogenesis (HP:0008669) | 1.79689176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.40601553 |
| 2 | TXK | 3.76543335 |
| 3 | FRK | 3.72966161 |
| 4 | TGFBR2 | 3.14788674 |
| 5 | KDR | 3.11922224 |
| 6 | MAP4K1 | 3.04098358 |
| 7 | TIE1 | 2.94597301 |
| 8 | KIT | 2.58210113 |
| 9 | MAP3K14 | 2.52723173 |
| 10 | CAMKK2 | 2.44065299 |
| 11 | TGFBR1 | 2.40777330 |
| 12 | IRAK4 | 2.28567265 |
| 13 | TEC | 2.15898900 |
| 14 | IKBKE | 2.15115090 |
| 15 | MAPKAPK3 | 2.11415675 |
| 16 | TYK2 | 1.97040838 |
| 17 | TBK1 | 1.86122781 |
| 18 | IRAK3 | 1.86095967 |
| 19 | JAK3 | 1.84162512 |
| 20 | PLK2 | 1.82087817 |
| 21 | BLK | 1.79962746 |
| 22 | NUAK1 | 1.74980234 |
| 23 | ZAP70 | 1.68711002 |
| 24 | CDK8 | 1.64763635 |
| 25 | IKBKB | 1.60466437 |
| 26 | NEK9 | 1.58088410 |
| 27 | BMPR1B | 1.53433362 |
| 28 | NLK | 1.51335912 |
| 29 | FLT3 | 1.45044955 |
| 30 | BTK | 1.41393682 |
| 31 | CAMK1D | 1.40718348 |
| 32 | ADRBK2 | 1.36010333 |
| 33 | ITK | 1.34781958 |
| 34 | ZAK | 1.32137797 |
| 35 | MAP2K3 | 1.29412814 |
| 36 | YES1 | 1.24513215 |
| 37 | CLK1 | 1.23491163 |
| 38 | GRK1 | 1.21792113 |
| 39 | CSF1R | 1.21133037 |
| 40 | NME2 | 1.19307181 |
| 41 | VRK1 | 1.18344343 |
| 42 | LCK | 1.17421497 |
| 43 | MUSK | 1.13287317 |
| 44 | MAP2K6 | 1.13254096 |
| 45 | GRK6 | 1.12833048 |
| 46 | STK16 | 1.09926142 |
| 47 | NEK6 | 1.09466064 |
| 48 | EIF2AK2 | 1.08268272 |
| 49 | TAOK2 | 1.07047815 |
| 50 | LYN | 1.06989745 |
| 51 | CDK9 | 1.04759052 |
| 52 | FGFR4 | 1.04337756 |
| 53 | CSK | 1.04274214 |
| 54 | SIK3 | 1.02790000 |
| 55 | INSRR | 1.02312073 |
| 56 | FGFR2 | 1.00929354 |
| 57 | TNIK | 0.98623950 |
| 58 | SYK | 0.92837004 |
| 59 | BRD4 | 0.91915493 |
| 60 | MAPK7 | 0.91898636 |
| 61 | TYRO3 | 0.91070579 |
| 62 | JAK1 | 0.90480152 |
| 63 | GRK7 | 0.90280712 |
| 64 | STK10 | 0.87383607 |
| 65 | MKNK1 | 0.86685317 |
| 66 | MST4 | 0.86247517 |
| 67 | MAP3K12 | 0.85977564 |
| 68 | WNK4 | 0.85099904 |
| 69 | BMPR2 | 0.84657795 |
| 70 | CHUK | 0.82689564 |
| 71 | SRPK1 | 0.79536163 |
| 72 | MAP3K13 | 0.77750307 |
| 73 | PIM1 | 0.77264955 |
| 74 | HCK | 0.75123415 |
| 75 | FGR | 0.72277639 |
| 76 | AKT3 | 0.70443125 |
| 77 | OXSR1 | 0.69812152 |
| 78 | MYLK | 0.69785173 |
| 79 | CAMKK1 | 0.69042248 |
| 80 | FGFR3 | 0.68011753 |
| 81 | MET | 0.67670571 |
| 82 | STK4 | 0.67321110 |
| 83 | IRAK1 | 0.66222237 |
| 84 | PDK1 | 0.65268383 |
| 85 | CDK6 | 0.64663866 |
| 86 | MAPK15 | 0.61814433 |
| 87 | PRKG2 | 0.61101476 |
| 88 | PIM2 | 0.60695479 |
| 89 | PIK3CG | 0.60458944 |
| 90 | MKNK2 | 0.60079405 |
| 91 | CAMK1G | 0.58641613 |
| 92 | PDK2 | 0.58557042 |
| 93 | IGF1R | 0.55802407 |
| 94 | DAPK2 | 0.53690853 |
| 95 | PTK2B | 0.52928866 |
| 96 | PRKAA2 | 0.52764337 |
| 97 | CDK3 | 0.52441442 |
| 98 | MAPK12 | 0.51183057 |
| 99 | ERBB3 | 0.50956403 |
| 100 | EGFR | 0.50541385 |
| 101 | ADRBK1 | 0.47388624 |
| 102 | RPS6KA4 | 0.47286539 |
| 103 | FES | 0.47150128 |
| 104 | BRSK2 | 0.44953615 |
| 105 | TAOK3 | 0.44408967 |
| 106 | MARK3 | 0.44278816 |
| 107 | RPS6KA5 | 0.43865742 |
| 108 | ERBB2 | 0.43011001 |
| 109 | TLK1 | 0.42948282 |
| 110 | MAP3K3 | 0.42925492 |
| 111 | EIF2AK3 | 0.42356015 |
| 112 | PIK3CA | 0.42337436 |
| 113 | CAMK4 | 0.41506401 |
| 114 | MAPK11 | 0.41494054 |
| 115 | ABL1 | 0.40754535 |
| 116 | TNK2 | 0.40704753 |
| 117 | MATK | 0.40457946 |
| 118 | CDK7 | 0.40414708 |
| 119 | FER | 0.40348033 |
| 120 | JAK2 | 0.39597852 |
| 121 | ATR | 0.38641373 |
| 122 | TRPM7 | 0.37987101 |
| 123 | MAPKAPK5 | 0.37588375 |
| 124 | LRRK2 | 0.34798685 |
| 125 | PRKCQ | 0.34341781 |
| 126 | MAPK4 | 0.34064360 |
| 127 | PRKCD | 0.33178422 |
| 128 | PRKCI | 0.33021948 |
| 129 | ACVR1B | 0.32625052 |
| 130 | RPS6KB2 | 0.32039853 |
| 131 | CSNK1G1 | 0.30592695 |
| 132 | FYN | 0.30427668 |
| 133 | BCKDK | 0.30340461 |
| 134 | MAPK3 | 0.29836523 |
| 135 | WNK1 | 0.27593923 |
| 136 | MAPKAPK2 | 0.26496884 |
| 137 | MAP4K2 | 0.24599143 |
| 138 | PRKCE | 0.23427301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.17491037 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.91875987 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66887906 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.54949318 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.50382962 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.07566402 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.07492701 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.07360111 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.05609968 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99074359 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88348832 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.78435285 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76618726 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.73655422 |
| 15 | Ribosome_Homo sapiens_hsa03010 | 1.67181306 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 1.63576122 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58604698 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.57894806 |
| 19 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.57681252 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.57592241 |
| 21 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.56314571 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55718239 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.55026908 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54176498 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.53195257 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.48992647 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.35578632 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.35428615 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30134921 |
| 30 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28563391 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27224603 |
| 32 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.26609428 |
| 33 | Phagosome_Homo sapiens_hsa04145 | 1.25833453 |
| 34 | DNA replication_Homo sapiens_hsa03030 | 1.21841818 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.20434138 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19548630 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.17939009 |
| 38 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.17901129 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.16666668 |
| 40 | Homologous recombination_Homo sapiens_hsa03440 | 1.15527513 |
| 41 | Mismatch repair_Homo sapiens_hsa03430 | 1.15461798 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.14444666 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10180603 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.10036191 |
| 45 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.09052977 |
| 46 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.08583624 |
| 47 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.08125465 |
| 48 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.04111450 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.03135308 |
| 50 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02488408 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.02300691 |
| 52 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.01858418 |
| 53 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.01223403 |
| 54 | Base excision repair_Homo sapiens_hsa03410 | 1.00139305 |
| 55 | RNA polymerase_Homo sapiens_hsa03020 | 0.99784401 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.99618317 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99528070 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96028164 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.95529702 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94201428 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92522186 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88687126 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86253125 |
| 64 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.86038348 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85301179 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.83970125 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.83536023 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.83511755 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 0.82523222 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82163599 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.81829817 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.80716697 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79579840 |
| 74 | Peroxisome_Homo sapiens_hsa04146 | 0.79173270 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.79139433 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.78963400 |
| 77 | Apoptosis_Homo sapiens_hsa04210 | 0.78246332 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.77673763 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.76594224 |
| 80 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.74402690 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.73932813 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.73394389 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.72914124 |
| 84 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72308223 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70315427 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.70125954 |
| 87 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.69274491 |
| 88 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67794315 |
| 89 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66339893 |
| 90 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65214680 |
| 91 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63372573 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61931933 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61318747 |
| 94 | Tuberculosis_Homo sapiens_hsa05152 | 0.60472477 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.60380904 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60125256 |
| 97 | Salmonella infection_Homo sapiens_hsa05132 | 0.58526553 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58168054 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57404604 |
| 100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55777133 |
| 101 | Phototransduction_Homo sapiens_hsa04744 | 0.54925329 |
| 102 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.52306410 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49559404 |
| 104 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48960144 |
| 105 | Spliceosome_Homo sapiens_hsa03040 | 0.48743622 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.47818507 |
| 107 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43917472 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43477864 |
| 109 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42572724 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41881765 |
| 111 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.41822278 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.40896376 |
| 113 | Purine metabolism_Homo sapiens_hsa00230 | 0.39916468 |
| 114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37344012 |
| 115 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37259813 |
| 116 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35663184 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35283283 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34992675 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34168755 |
| 120 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.33339415 |
| 121 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.32515858 |
| 122 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27753877 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27452892 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23552625 |
| 125 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21038238 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.19365285 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18384750 |
| 128 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.18197660 |
| 129 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.18197099 |
| 130 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.17657899 |
| 131 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.17606595 |
| 132 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16720266 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.14224988 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.13110440 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.11595368 |
| 136 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.10445366 |
| 137 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.09403625 |
| 138 | Mineral absorption_Homo sapiens_hsa04978 | 0.08784368 |

